Singapore: +65-31631880 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719

          

Clinical Trial News

Alzheimer's vaccine steps closer with new study

A new vaccine combination has proven successful in mouse models of Alzheimer's, new study reveals, and it could be tested in humans within 3-5 years.

Moffitt Cancer Center launches nationwide e-cigarette study

The research study seeks 2,500 adult smokers who use both cigarettes and e-cigarettes.The use of electronic cigarettes ("e-cigarettes") has increased dramatically in recent years.

Prostate cancer: Unexpected results from international Phase III study

A recently published international clinical Phase III trial of a promising drug for treating advanced prostate cancer ended with surprising results: the new therapeutic agent failed to achieve any...

International collaboration to create new cancer models to accelerate research

An international project to develop a large, globally accessible, bank of new cancer cell culture models for the research community launches today (Monday).

Colorectal cancer: Pivotal Phase III data for Xilonix presented

XBiotech Inc., developer of next-generation True Human™ antibody therapies, has presented positive results from a pivotal Phase III trial of Xilonix™, the company's lead monoclonal...

Pancreatic cancer survival could be increased with new treatment combo

In mice with pancreatic cancer, researchers found adding an investigational drug to immunotherapy and chemotherapy more than tripled their survival.

Regorafenib shows significant survival gains in refractory liver cancer

Phase III trial confirms efficacy and safety of new second-line agent.Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with...

Pluristem reports data showing PLX-PAD cells effective in treating Duchenne muscular dystrophy

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, has reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne...



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook